Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
about
Statins for women with polycystic ovary syndrome not actively trying to conceiveStatins for women with polycystic ovary syndrome not actively trying to conceiveGenetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary SyndromePolycystic ovary syndrome: clinical implication in perimenopauseComplications and challenges associated with polycystic ovary syndrome: current perspectivesEndothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenCancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancerScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Evaluation of homocysteine levels in patients with polycystic ovarian syndrome.Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transitionPrevalence of elevated glycated hemoglobin concentrations in the polycystic ovary syndrome: anthropometrical and metabolic relationship in amazonian womenPolycystic ovarian syndrome: diagnosis and management.Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.Age at first birth and risk of later-life cardiovascular disease: a systematic review of the literature, its limitation, and recommendations for future research.Nonalcoholic fatty liver disease and polycystic ovary syndrome.MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.The optimal diet for women with polycystic ovary syndrome?Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study.PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Pharmacological treatment of obesity in patients with polycystic ovary syndrome.Polycystic ovary syndrome: not ovarian, not simple, unkind.Menstrual irregularity and cardiovascular mortality.Epidemiology, diagnosis, and management of polycystic ovary syndromePolycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder.An Association Study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in Women with Polycystic Ovary Syndrome from West Azerbaijan Province, IranPredictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.Assessment of symptoms of urinary incontinence in women with polycystic ovary syndromeThe prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.Vascular effects of estrogenic menopausal hormone therapy.The pathophysiology of polycystic ovary syndrome.Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study.Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study
P2860
Q24234599-F7AA3B1C-AC32-4FCC-903B-BFEC8C747FC6Q24236132-4E720203-3DB4-4E45-85FA-51741D6F948AQ26745164-C63BFA59-2773-4BC9-B8FB-639A31D7D14BQ26795581-D5A4DCB8-2D49-4239-B9E2-A752F35AC55BQ26799566-D9A6DE56-7AEA-4A98-ACAA-5E084C2300AEQ26851688-6DA92A63-7527-4CBE-B715-3CD1B6A6D214Q27021307-F24E30F7-FD1F-453D-A0B5-7289673033C8Q28222481-1374FCAD-8B96-4388-9851-20AA4B653320Q28390200-BA4FE524-09A2-4AB2-8AD5-1DD73D63FA47Q30356743-9BD725AC-E459-46BE-B284-3AF3420DC55DQ33569169-47799F2E-1CAD-4AAA-B296-1AA4C49BFB98Q33621940-2B4079C7-48AC-4570-9D9E-0D608A0B51E4Q33682425-FACD3B5B-E093-4A0F-B64F-7FA3F12A0724Q33688327-7D3482BC-F22D-446E-8A34-5F674C16218AQ33723471-B8C0D281-A5AC-409A-BA95-5B042441DEAAQ33736113-4140D9E6-FC5D-44CB-9BBC-A27129C0F3AFQ33876483-0415F76A-BC2B-4A56-B2B8-5417666E14B2Q33886930-A2077C3C-A8AF-4B4D-8460-EAD8FA545B60Q33904576-0F7E20CB-8F2D-44B2-A231-59ED6AC4C993Q33989484-796E84A2-2F60-4BC5-B490-63A4233A7263Q34099068-61877E4D-A519-4541-8B12-D77E309EF0D5Q34113211-60C88F5B-BFDF-40C1-8C79-1269CBC2CCA0Q34165728-B54BA796-BEDC-4F0D-9DFB-C4EF65008BDBQ34194665-A38620E6-6F0E-496F-A8C6-27C25B056E52Q34375771-CE7DA737-8FF7-4D20-8637-7E8F4A6F59C4Q34442683-310AFCFA-22FA-46D0-B76B-246DF8B19558Q34565871-2160105D-3802-4982-B525-DD90BF28D0C6Q34571805-38832FEC-FA4A-4D99-908C-2373B3BF7062Q34658641-BB2BFA89-C97E-4A1C-B277-4AFCB93947FCQ34698200-8C3E1DD4-55A2-4D71-A351-4703EE2B7995Q35026437-12B05B4C-25E6-4C30-B73A-D8BB5157D25FQ35276405-5F3E67FB-9707-4C8A-BB69-944D01F35E34Q35297432-6867555E-65F2-42A9-9FA7-33E21422BE98Q35473306-6D74756C-274A-4BF3-BF5C-B777BD9405BFQ35544923-FB3CFDD1-6E55-41ED-BE4B-D7ABD9AB6AF8Q35583311-F304E6AE-EED4-476B-86F4-CF4E37130BD5Q35608887-E4D3AC1A-9B16-4D75-807A-FD173AE3743EQ35641060-1CD136E0-D57C-492F-8889-F65EB9B736E9Q35770685-9AB85DEA-A006-4336-9419-B5D9CF34D0BCQ35787725-43714203-E93F-4930-A47E-CF5572301E07
P2860
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Cardiovascular disease in wome ...... a retrospective cohort study.
@en
Cardiovascular disease in wome ...... a retrospective cohort study.
@nl
type
label
Cardiovascular disease in wome ...... a retrospective cohort study.
@en
Cardiovascular disease in wome ...... a retrospective cohort study.
@nl
prefLabel
Cardiovascular disease in wome ...... a retrospective cohort study.
@en
Cardiovascular disease in wome ...... a retrospective cohort study.
@nl
P2093
P2860
P1476
Cardiovascular disease in wome ...... a retrospective cohort study.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.2000.01000.X
P577
2000-05-01T00:00:00Z